EPCAM and neoplasm: As EpCAM is not tumour-specific, but rather is tumour-associated and also expressed on normal epithelial tissue (Balzar et al, 1999), high affinity conventional mAbs may be disadvantageous, with therapeutic concentrations that cause severe adverse events.